Education
About Us
Working with TipRanks
Follow Us
Olaplex Holdings (OLPX)
NASDAQ:OLPX
Top Page
Olaplex Holdings
(NASDAQ:OLPX)
Select Model
Select Model
Rating:46Neutral
Price Target:
$1.00
▼(-21.26% Downside)
Action:ReiteratedDate:03/06/26
Overall score reflects weakened financial performance (return to net losses, margin compression, and declining free cash flow) as the primary drag. Technicals add near-term caution with the stock below key short-term moving averages. The earnings call provides some support via steady gross margins, liquidity, and guidance pointing to stabilization later in FY2026, but modest sales guidance and near-term EBITDA pressure keep the risk profile elevated.
Positive Factors
High gross margins
Sustained ~71% adjusted gross margins provide structural pricing/production advantage in prestige haircare. That margin buffer supports reinvestment in marketing, R&D and channel initiatives while insulating the business from some top‑line softness, improving odds of profitable recovery over several quarters.
Positive cash generation & liquidity
Consistent positive operating cash flow and a multi‑hundred million dollar cash balance give the company a durable financial runway to fund product launches, marketing investments and acquisitions without immediate capital raises, lowering execution risk during a multi‑quarter turnaround.
Innovation and brand relaunch
A measurable brand relaunch, clinically backed new product (No.3+), and strategic acquisition expand the company’s innovation moat. These durable product and technology investments can re‑engage professionals and consumers, improving repeat rates and long‑term category relevance if execution continues.
Negative Factors
Profitability deterioration
A move to negative net margins signals structural pressure on operating profitability and reduces internal funding for growth. Reversing this decline requires sustained revenue improvement or durable cost reductions; absent that, the company risks prolonged earnings weakness and reduced return on invested capital.
Flat full‑year revenue
After steep prior declines, revenues stabilizing but not growing implies limited market share recovery and weak secular demand momentum. Persistent flat top‑line constrains operating leverage, makes margin restoration harder, and extends the timeline to justify higher operating spend or marketing investments.
Higher operating spend & front‑loaded marketing
Material SG&A and S&M increases, some front‑loaded behind relaunch, compress near‑term EBITDA and elevate execution risk if customer response lags. Elevated fixed spending reduces flexibility and can prolong negative margin dynamics unless marketing efficiency and sell‑through sustainably improve.
Olaplex Holdings (OLPX) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$850.14M
Dividend YieldN/A
Average Volume (3M)1.15M
Price to Earnings (P/E)―
Beta (1Y)1.44
Revenue Growth-3.47%
EPS Growth-111.68%
CountryUS
Employees231
SectorConsumer Cyclical
Sector Strength84
IndustrySpecialty Retail
Share Statistics
EPS (TTM)0.01
Shares Outstanding669,402,650
10 Day Avg. Volume754,587
30 Day Avg. Volume1,146,334
Financial Highlights & Ratios
PEG Ratio0.66
Price to Book (P/B)1.02
Price to Sales (P/S)2.11
P/FCF Ratio15.31
Enterprise Value/Market Cap1.06
Enterprise Value/Revenue2.14
Enterprise Value/Gross Profit3.61
Enterprise Value/Ebitda12.88
Forecast
1Y Price Target
$1.83Price Target Upside44.09% Upside
Rating ConsensusHold
Number of Analyst Covering9
EPS Forecast (FY)0.08
Revenue Forecast (FY)$427.18M
Olaplex Holdings Business Overview & Revenue Model
Company DescriptionOlaplex Holdings, Inc. manufactures and sells hair care products. The company offers hair care shampoos and conditioners for use in treatment, maintenance, and protection of hair. It provides hair care products to professional hair salons, retailers, and everyday consumers. The company was founded in 2014 and is based in Santa Barbara, California.
How the Company Makes MoneyOlaplex makes money primarily by selling branded haircare products. Its revenue model is centered on product sales through two main channels: (1) Professional (sales to salons, stylists, and professional distributors), where products are used in-salon and also retailed to salon clients; and (2) Specialty Retail (sales to beauty retailers and their e-commerce platforms, as well as Olaplex’s own direct-to-consumer online sales). Revenue is recognized from the transfer of products to customers (e.g., retailers, distributors, salons, or end consumers for direct sales). Earnings are influenced by factors such as brand demand, distribution breadth across professional and retail partners, product mix (treatments vs. maintenance/styling), pricing/promotional activity, and the company’s ability to drive repeat purchases and new customer adoption through marketing and product innovation.
Olaplex Holdings Key Performance Indicators (KPIs)
Any
Net Sales by Geography
Examines revenue distribution across various regions, providing insight into market strength, potential growth areas, and exposure to regional economic fluctuations.
Examines revenue distribution across various regions, providing insight into market strength, potential growth areas, and exposure to regional economic fluctuations.
Data provided by:
The Fly
The FlyOlaplex Holdings Earnings Call Summary
Earnings Call Date:Mar 05, 2026
(Q4-2025)
| % Change Since: |
Next Earnings Date:May 13, 2026
Earnings Call Sentiment Neutral
The call highlights meaningful progress in brand relaunch, professional channel reengagement, a robust innovation pipeline (including the No. 3+ launch), improved gross margins, and positive operating cash flow. However, these achievements are tempered by notable margin compression versus prior year, a flat full‑year top line, continuing annual sell‑through weakness, specialty retail declines, and near‑term EBITDA pressure due to front‑loaded marketing and elevated operating spend. Management frames the moves as deliberate investments to stabilize and accelerate long‑term growth, while 2026 guidance is cautious and front‑weighted toward second‑half improvement.Q4-2025 Updates
Positive Updates
Full-Year Net Sales and Stability
Net sales were flat at $423.0M for fiscal 2025, stabilizing after declines of 35% in 2023 and 8% in 2024; company exited the year with improving sell-through trends and positive December sell-through in key accounts.
Fourth Quarter Revenue Growth
Q4 net sales were $105.1M, up 4.3% year over year, led by strong holiday performance across professional and DTC channels.
Strong Professional Channel Performance
Professional channel net sales in Q4 increased 18.9% year over year to $36.8M; professional channel net sales grew 5.5% for the full year as management reengaged pros via blitz activations, education, and backbar offerings.
Direct-to-Consumer Momentum
DTC grew 6.6% year over year in Q4 to $43.6M and 3.1% for the year, driven by a revamped digital strategy, strong holiday/wash-and-shine kit performance, and outperformance on TikTok Shop.
Improved Gross Margins and Cash Flow
Adjusted gross profit margin was 70.6% in Q4, up 200 basis points YoY; fiscal 2025 adjusted gross margin was 71.8% (up 40 bps). The company generated positive operating cash flow of $58.7M for the year and ended the quarter with $318.7M in cash.
Adjusted EBITDA and Margin Stabilization
Adjusted EBITDA for fiscal 2025 was $93.9M representing a 22.2% margin. Management describes this margin range as a stabilized base for executing the transformation and long-term growth.
Brand Relaunch and Measurable Marketing Uplift
Brand relaunch produced measurable gains: brand awareness +7%, sentiment +3%, earned media value +14%; engaged ~4,000 creators and generated ~2 billion impressions during 2025 campaigns.
Innovation Pipeline and Strategic Acquisition
Company delivered four of the top five prestige hair care launches (Circana) in 2025, launched No. 3+, claims of clinically proven results (3x stronger, 3x softer after one three-minute use), and completed acquisition of Pervala Bioscience to expand bio‑inspired innovation and white space opportunities.
Working Capital Discipline
Inventory decreased to $60.2M from $75.2M in 2024 (down $15.0M), reflecting improved working capital management amid transformation efforts.
Negative Updates
Adjusted EBITDA Margin Compression YoY
Adjusted EBITDA margin declined materially to 22.2% for the year from 30.7% in the prior year; Q4 adjusted EBITDA margin was 12.2% (vs. 17.4% in Q4 2024), reflecting increased marketing and people investments.
Top-Line Growth Limited / Flat Full Year
Full‑year net sales were flat at $423.0M versus the prior year, indicating limited top-line recovery despite brand and innovation investments.
Specialty Retail Decline
Specialty retail net sales declined 14.5% in Q4 to $24.7M and were down 8.3% for the year, reflecting intentional international distribution realignment and headwinds to that channel.
Sell-Through Still Down on Annual Basis
Although sell-through improved sequentially and December showed positive trends in key accounts, consolidated sell-through remained down on an annual basis for 2025.
Near-Term Pressure and Front-Loaded Costs
2026 guidance embeds a weak Q1 with sales below the full-year range and EBITDA 'significantly pressured' in Q1 due to front-loaded marketing for the No. 3+ launch; management expects marketing efficiency to improve later in 2026.
Higher Operating Spend
Adjusted SG&A rose to $211.4M for the year (an increase of $40.8M YoY); sales & marketing increased $26.7M for the year as the company invested to rebuild brand and infrastructure.
Leverage and Balance Sheet Position
Company ended the quarter with $318.7M in cash and $352.3M in debt (net debt ~ $33.6M), indicating modest net leverage despite strong cash generation.
Operational Complexity and Execution Risks
Management cited operational complexity from new packaging rollout, multi-year innovation pipeline, international realignment, and supply chain transitions, which are reflected in conservative guidance (2026 net sales -2% to +3%) and could affect execution cadence.
Company Guidance
Management guided fiscal 2026 net sales of approximately -2% to +3% versus fiscal 2025 (FY‑2025 net sales $423.0M), adjusted gross profit margin of 71%–72% (FY‑2025 adj. gross margin 71.8%; Q4 70.6%, +200 bps YoY), and adjusted EBITDA margin of 21%–22% (FY‑2025 adj. EBITDA $93.9M, 22.2%; Q4 adj. EBITDA $12.9M, 12.2%); they expect sell‑through to improve sequentially and turn positive for the year but caution Q1 sales will be below the full‑year cadence and Q1 EBITDA will be “significantly pressured” due to front‑loaded marketing supporting the No. 3+ launch, with marketing efficiency improving later in the year, non‑S&M operating expense rising as 2025 investments annualize, and the outlook assuming no material tariff impact (cash $318.7M, debt $352.3M, inventory $60.2M).Olaplex Holdings Financial Statement Overview
Summary
Mixed fundamentals. Revenue was flat (~$423M) but profitability deteriorated sharply with net margin turning negative in 2025. Gross margin remains strong (~69%) and leverage improved (debt-to-equity ~0.40), but free cash flow fell (~19% YoY) and cash-flow coverage weakened, raising execution risk if profits don’t recover.Income Statement
Revenue has been essentially flat in 2025 versus 2024 (~$423M), but the bigger issue is profitability: net margin swung from +4.6% (2024) to -2.2% (2025) with net income turning negative. While gross margin remains strong and stable (~69%), operating profitability deteriorated sharply versus prior years (2021–2023 showed meaningfully higher operating and net margins), signaling higher costs and/or reduced pricing power and a weaker earnings trajectory.34
Negative
Balance Sheet
Leverage looks manageable and improving: debt-to-equity declined to ~0.40 in 2025 from ~0.74 in 2024 and ~0.78 in 2023, giving the company more balance-sheet flexibility. Equity remains sizable (~$879M) versus debt (~$352M). The key weakness is returns: profitability deterioration pushed return on equity slightly negative in 2025, which reduces the quality of the balance sheet despite the healthier leverage profile.62
Positive
Cash Flow
Cash generation remains positive with operating cash flow and free cash flow both at ~$59M in 2025, but cash flow fell materially year over year (free cash flow down ~19% in 2025). Cash flow still exceeds the net loss (free cash flow to net income is positive given negative earnings), which is a near-term support. However, cash flow relative to the company’s obligations weakened versus 2024 (coverage dropped from ~2.21x to ~0.57x), suggesting reduced cushion if profitability does not recover.48
Neutral
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 422.96M | 422.67M | 458.30M | 704.27M | 598.37M |
| Gross Profit | 250.06M | 292.29M | 318.63M | 519.55M | 473.82M |
| EBITDA | 70.16M | 143.39M | 186.77M | 398.34M | 385.70M |
| Net Income | -9.25M | 19.52M | 61.59M | 244.07M | 220.78M |
Balance Sheet | |||||
| Total Assets | 1.50B | 1.77B | 1.74B | 1.70B | 1.56B |
| Cash, Cash Equivalents and Short-Term Investments | 318.73M | 585.97M | 466.40M | 322.81M | 186.39M |
| Total Debt | 352.29M | 650.46M | 655.77M | 662.77M | 758.20M |
| Total Liabilities | 618.10M | 893.32M | 895.37M | 916.72M | 1.04B |
| Stockholders Equity | 879.39M | 874.40M | 844.97M | 780.96M | 524.30M |
Cash Flow | |||||
| Free Cash Flow | 58.33M | 138.18M | 173.92M | 254.67M | 198.26M |
| Operating Cash Flow | 58.66M | 143.07M | 177.53M | 255.32M | 200.03M |
| Investing Cash Flow | -12.61M | -4.89M | -3.61M | -2.68M | -6.26M |
| Financing Cash Flow | -313.29M | -18.61M | -30.33M | -116.22M | -18.34M |
Olaplex Holdings Technical Analysis
Negative
1.27
Price Trends
1.53
Negative
1.35
Negative
1.37
Negative
Market Momentum
-0.09
Positive
40.26
Neutral
25.23
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For OLPX, the sentiment is Negative. The current price of 1.27 is below the 20-day moving average (MA) of 1.46, below the 50-day MA of 1.53, and below the 200-day MA of 1.37, indicating a bearish trend. The MACD of -0.09 indicates Positive momentum. The RSI at 40.26 is Neutral, neither overbought nor oversold. The STOCH value of 25.23 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for OLPX.
Olaplex Holdings Risk Analysis
Olaplex Holdings disclosed 51 risk factors in its most recent earnings report. Olaplex Holdings reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Olaplex Holdings Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
64 Neutral | $1.31B | 7.65 | 23.43% | ― | -0.42% | 31.64% | |
63 Neutral | $23.10B | 25.17 | 44.07% | ― | 5.45% | 4.28% | |
63 Neutral | $10.10B | 57.58 | 55.17% | ― | 9.80% | -46.84% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
56 Neutral | $4.02B | 7.11 | -44.22% | 4.16% | -1.04% | -20.88% | |
55 Neutral | $5.21B | 33.41 | -15.36% | ― | 1.98% | -20.98% | |
46 Neutral | $850.14M | -96.53 | -1.05% | ― | -3.47% | -111.68% |
* Consumer Cyclical Sector Average
OLPX
Olaplex Holdings
1.27
-0.08
-5.93%
BBWI
Bath & Body Works
19.98
-9.07
-31.23%
SBH
Sally Beauty
13.52
5.02
59.06%
ULTA
Ulta Beauty
520.65
179.76
52.73%
ETSY
Etsy
54.12
9.19
20.45%
CHWY
Chewy
24.33
-7.99
-24.72%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.